I was happy with the AGM. They clearly are excited about OmniCar - and reinforcing the message that they are having a lot of discussions.
Unsurprising that we won’t get a readout of the ptx-100 trial until Q2 2021 (and same for Ptx-200 AML)
and I’m pleased that he went to some steps to address Ptx-200 ovarian and breast cancer. While i wouldn’t expect to see any real developments any time soon - at least they’re “in discussions now” about re pivoting both trials
PTX Price at posting:
6.8¢ Sentiment: Hold Disclosure: Held
